Local company seeing
significant growth in global lab services

Monroe County Executive Maggie Brooks and Arthur Glenz, president and CEO of ACM Medical Laboratory, Inc., hosted a ribbon cutting ceremony for ACM's newly expanded facility located at 160 Elmgrove Park in the Town of Gates.

"ACM's expansion represents a $2 million investment in our community and more high quality, good paying jobs in Monroe County," said Brooks. "Health care and its related industries, including biotechnology and life sciences, represent a vital and growing segment of our economy, and a significant area of opportunity for our community as we move forward. ACM is a global leader in laboratory testing and we are proud they decided to grow their business here in Monroe County."

ACM has experienced substantial growth in global central lab services with its existing client base, as well as with new pharmaceutical and biotechnology companies. Since 2004, ACM's total workforce has grown by 20 percent. ACM currently employs 339 in Monroe County. The expansion will create 30 new full-time jobs and 36 part-time jobs.

ACM's main facility expanded to 70,000 square feet with the addition of a 15,500 square foot new third floor. The expansion more efficiently supports the current and anticipated growth of the business. ACM's global operations extend to more than 60 countries, including the United States, Europe (including Eastern Europe and Russia), Australia, Asia, Israel and South Africa with all tests conducted and managed from central lab facilities. Last year, ACM expanded its capabilities to conduct trials in India.

"We are making a significant impact in this industry because of our consistent and extremely high customer-service standard, world-class analytical capabilities and global reach," said Glenz. "We strive to build long-lasting relationships with our clients, and this growth is further validation that our clients value the peace of mind they've become accustomed to as a result of our high-caliber teams and superior service."

Over the past year, ACM has enhanced its track record with trials in oncology, female health, metabolic syndrome and infectious diseases and has continued to invest in its analytical capabilities. The company announced an expanded pathology services department to respond to all testing needs more consistently and cost-efficiently. It is also expanding its Flow Cytometry department to meet a significant increase in demand for this highly specialized discipline.

May 20, 2007